- Lobbying
- Casey AND Brouhard
Lobbying Arrangements Results for 'Casey Brouhard'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to type 1 diabetes population screening and drug therapies. |
Provention Bio, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to physician reimbursement and prior authorization. |
Teleflex Incorporated
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to remote cardiac monitoring reimbursement cuts. |
BioTelemetry Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to Medicare reimbursement of advanced wound care and surgical and sports medicine products. |
Organogenesis
|
Arnold & Porter Kaye Scholer LLP | |||
Details Medicare coverage and reimbursement for ambulatory neurodiagnostic testing. |
Stratus
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to funding from Appropriations Acts for hospital-based mental health, child advocacy, pediatric, and primary care services; capital projects; and Congressionally Directed Spending (C... |
San Francisco General Hospital Foundation
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to health care accreditation, Medicare Advantage plans, including Medicare Advantage Special Needs Plans (SNP) reviews, telehealth, mental health parity, health equity, pharmacy bene... |
URAC, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to disease surveillance and pandemic preparedness, and the Pandemic All-Hazards Preparedness (PAHPA) reauthorization, including the Pandemic and All-Hazards Preparedness and Response... |
InductiveHealth Informatics
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to pharmacy benefit managers and the 340B Program. Issues related to pharmacy benefit managers and the 340B program. Issues related to the clinical and overall benefit of anti-obesit... |
Novo Nordisk, Inc.
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to Medicare coverage of marriage and family therapist (MFT) services and mental health counselor (MHC) services. Issues related to the Mental Health Access Improvement Act as include... |
American Counseling Association
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to coordinated care models for childrens health, telehealth, the Childrens Health Insurance Program (CHIP), medical education, high-cost specialty drugs, pediatric mental health, hos... |
Childrens Health System of Texas
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to access, coverage, a... |
Exelixis, Inc.
Oncology-focused biotechnology company |
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to lab analysis and review of diagnostics and lab developed tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2023 (H.R. 2369). |
Adaptive Biotechnologies
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to funding for pediatric mental health care, the Childrens Hospital Graduate Medical Education (CHGME) program, and Congressionally Directed Spending (CDS) and Community Project Fund... |
Children's Hospital of The King's Daughters
|
Arnold & Porter Kaye Scholer LLP | |||
Details Medicare reimbursement of radiopharmaceuticals and nuclear medicine and Medicare reimbursement of cardiac PET scans, including the Facilitating Innovative Nuclear Diagnostics (FIND) Act (H.R. 1199 ... |
Society of Nuclear Medicine and Molecular Imaging
|
Arnold & Porter Kaye Scholer LLP | |||
Details Issues related to the manufacturing of infant formula and issues related to over-the-counter birth control. Issues related to the manufacturing of infant formula. |
Perrigo Company plc
|
Arnold & Porter Kaye Scholer LLP | |||
Details Engagement on FY24 appropriations requests related to furthering Liebers mission of understanding the genetic and molecular mechanisms behind schizophrenia and brain disorders to improve the lives ... |
Lieber Institute for Brain Development
|
Arnold & Porter Kaye Scholer LLP |